Top news of the week: 18.03.2021.
Companies And Industries
Solid Bio safely doses DMD gene therapy after exiting FDA hold
Solid Biosciences has given its Duchenne muscular dystrophy gene therapy without causing the sort of adverse events that forced it to shutter the study in 2019. The experience provides ...
Novavax links vaccine to full protection against severe COVID-19 caused by emerging variants
Novavax has linked its COVID-19 vaccine to 100% efficacy against severe disease in countries where variants of concern are prevalent. The final phase 3 data suggest NVX-CoV2373 may protect ...
Bluebird bio CMO quits amid a roller coaster year and upcoming split
Bluebird bio’s chief medical officer David Davidson, M.D., is hitting the exit, though remaining as a consultant, as the biotech looks to navigate through its gene therapy issues.
Clinical Catch-Up: March 8-12
It was another busy week for clinical trial announcements. Here’s a look including trials for COVID-19, migraine, Parkinson's disease, Alzheimer's, HIV and more.
Gilead, Novo Nordisk push NASH cocktail deeper into the clinic
After being encouraged by some early readouts, Gilead and Novo Nordisk are doubling down on their fatty liver R&D pact by kick-starting a midstage nonalcoholic steatohepatitis combo trial ...
Longboard, Prometheus Hit the Market with Hopes of Raising Over $250 Million Combined
The two pharmaceutical companies are going public and anticipate raising more than $250 million to advance research and development programs and support their business initiatives.
Former Biotech Director Charged with Obstruction of Justice Over Attempts to Acquire Neurotoxin Ricin
The U.S. Attorney’s Office for Massachusetts charged Ishtiaq Ali Saaem, 37, with obstruction of justice for lying about his attempts to acquire 100 castor bean packets in order to develop ...
Swabhiman Bharat: Kiran Mazumdar-Shaw's journey of creating Biocon
Kiran Mazumdar-Shaw, Chairperson of Biocon, originally trained to become a brewer in Australia before returning to India to become a brew-master in the 1970s but she struggled to find a ...